The Paxlovid pills are being developed at Pfizer’s two Irish plants in Ringaskiddy and Newbridge. Picture: Reuters
Pfizer’s new anti-viral drugs for Covid-19 will only be prescribed for “high-risk patients” for now, but may provide benefits to the wider public in time, according to the scientist who developed the treatment. Dr Annaliesa Anderson, the clinical development lead on the Paxlovid antiviral programme, was speaking to the Business Post from New Jersey in the US.Subscribe from just €1 for the first month!
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
New bill may push more legal costs on those who take insurers to court | Business PostRobert Troy: ‘If someone wants to reject their award and bring it to court and the court doesn’t increase the award any further, well then, they're going to have to pay for that’ obraonain now this is a good thing and will help
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »
Ronan to make new play for Dublin portfolio after legal case dropped | Business PostDeveloper may be seeking a new partner to bid for three landmark properties after ongoing dispute with US group Fortress is resolved out of court
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »
ESB’s new gas power contracts triple in value | Business PostWhistleblower has accused semi-state of abusing market position and ‘lowballing’ offers in earlier auctions
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »